Introduction and historical perspective
Glial cells exist throughout the CNS. Estimates regarding glia-toneuron ratios vary 1, 2 . Most likely, glia are present in numbers that are at least equal to, or exceeding, those of neurons 2 , and ~20-40% of the total number of cells in mammalian brains are specialized glia called astrocytes 2 , with considerable variability between species and brain areas. Mammalian brain neuronal circuits are built in networks of astrocytes, but the ratio of astrocytes to neurons varies between areas such as cerebral cortex, where astrocytes outnumber neurons, and cerebellum, where neurons greatly outnumber astrocytes. Astrocytes are sparse in areas with a high density of neuronal cell bodies, such as cerebellar granule and hippocampal pyramidal cell layers, whereas they are replete in areas with dendrites and axons. Hence, at a fundamental level, there is regional diversity in astrocyte-to-neuron ratios, but the functional relevance and the regional differences in volumes occupied by astrocytes is not understood. It is remarkable how little we know about the functional diversity of astrocytes, especially as neuroscience seeks to map entire brain circuits 3 . Nonetheless, several functions are now well accepted and include roles for astrocytes in ion homeostasis, neurotransmitter clearance, and synapse formation and removal, as well as contributions to neurovascular coupling.
Early anatomical studies revealed a range of astrocyte morphologies, hinting at diversity and functional specializations 4 , and these observations have been extended with the latest imaging methods 5 . The distinction between protoplasmic and fibrous astrocytes is now well established and is based on morphological differences and their locations in gray and white matter, respectively 6, 7 . In contrast, studies of astrocyte function have lagged behind and an appreciation of functional diversity has been slower to emerge. In large part, this reflects the fact that electrophysiology, which so advanced the understanding of neurons, is not ideally suited to study glia. Astrocytes 8 , similar to other glia, are largely electrically silent 9 , rarely deviate from the K + equilibrium potential by more than a few millivolts 10 and display a predictable 9 57 -mV depolarization for a tenfold increase in extracellular K + . Astrocytes also have low membrane resistances and extensive small branchlets; the voltage changes in these distal structures may not be detected using somatic electrophysiology. In 1967, Stephen Kuffler, a pioneering glial researcher, perhaps recognizing their threadbare electrical signaling potential, wrote 9 Concerning the role of glial cells, a variety of mechanisms will probably emerge. Obvious gaps in our knowledge which prevent the formulation of more precise hypotheses relate to detailed information about the biochemical properties of various glial cells and the mechanisms of neuron-glia interactions.
Much progress has been made in the years since, and a mechanistic understanding of astrocytes is emerging. Key advances have arisen with the use of modern imaging methods, physiological studies of astrocyte-neuron interactions, molecular genetics, protein engineering, transcriptomics and studies of how astrocytes respond to injury. We focus on some of the latest insights that shed new light on astrocyte functional dynamics, diversity and specializations in neural circuits and microcircuits.
Readers should consider several general reviews on astrocyte heterogeneity 11, 12 and development 13, 14 . Here we seek to tackle astrocyte diversity from a different angle. In Box 1, we list questions that relate to functional diversity. We summarize evidence related to these and advance the concept that astrocytes represent a diverse population of cells with diverse dynamics and functions.
Diversity of astrocyte molecules and markers
Glial fibrillary acidic protein (GFAP) was the first molecular marker to be robustly associated with astrocytes 15, 16 . Although GFAP is often regarded as the prototypical astrocyte marker, this status carries two important caveats. First, although upregulation of GFAP is a sensitive r e v i e w and reliable marker of astrocytes that are responding to CNS insults, in healthy tissue, many astrocytes do not express GFAP in amounts detectable by immunohistochemistry. Thus, the absence of detectable GFAP does not indicate the absence of astrocytes that can be detected by ultrastructural evaluation or by other markers such as S100β, glutamine synthetase or Aldh1L1 (see ref. 17) . Astrocytes from different brain regions can exhibit pronounced differences in GFAP levels, including locally intermingled astrocytes. Nearly all astrocytes in healthy hippocampus express readily detectable GFAP, whereas few astrocytes do so in thalamus. In cerebral cortex, many astrocytes in superficial and deep layers express detectable GFAP, whereas few astrocytes do so in middle layers. Similar differences exist in gray matter regions across the CNS, whereas most white matter astrocytes constitutively express detectable GFAP. Findings such as these were among the first to hint at astrocyte molecular diversity. It is also noteworthy that different isoforms and splice variants of GFAP (α, β, γ, δ and κ) exist and may be variably expressed in different astrocytes 18 . The second major caveat regarding GFAP as an astrocyte marker is that it is expressed by other cell types in the CNS and peripheral organs 17, 19 . In the CNS, GFAP-expressing progenitor cells derived from radial glia appear during late development and generate neurons and glia in various CNS regions throughout life 20, 21 . Thus, detectable GFAP expression is neither required nor sufficient to identify a cell as a mature differentiated astrocyte.
As other molecules produced by astrocytes have been identified, examples of astrocyte molecular diversity have emerged, particularly across CNS regions. For example, astrocytes exhibit differences in glutamate transporters GLT-1 (EAAT2) and GLAST, such that GLT-1 (EAAT2) expression is higher in hippocampus, cerebral cortex and striatum, whereas GLAST expression is higher in cerebellum 22 . The gap junction protein connexin 30 (Cx30) is expressed by gray, but not white, matter astrocytes, and gray matter astrocytes in globus palidus express high Cx30 levels, whereas those in neighboring striatum express low levels 23 . The potassium channel Kir4.1 is expressed at a low level in white matter astrocytes, and at a variable level among gray matter astrocytes, with particularly high levels in hippocampus and cerebellum 24 . Recent large-scale astrocyte transcriptome analyses have strengthened the notion of molecular diversity among astrocytes in different regions, and provide evidence that different stimuli can change astrocyte transcriptional profiles in different ways [25] [26] [27] [28] [29] .
There is also molecular heterogeneity among astrocytes locally interspersed in the same region. For example, a subpopulation of astrocytes in human cerebral cortex expresses the cell adhesion molecule CD44 (ref. 30) . Using genetic knock-in targeting strategies, Garcia et al. 31 showed that the sonic hedgehog (SHH) receptor Gli1 is selectively expressed by scattered astrocytes in murine cerebral cortex and that attenuation of neuronal SHH increased GFAP expression only in Gli1-expressing astrocytes, thereby demonstrating the capacity for selective signaling from neurons to a specific astrocyte subpopulation. Below, we consider how Sema3a expression identifies astrocyte subpopulations in the spinal cord 32 .
To date, most genetic targeting strategies directed at astrocytes have been based on molecular markers that are chosen because they target as broad a range of astrocytes as possible, such as GFAP, GLAST, GLT-1 (EAAT2), Cx43 or Aldh1L1. Few targeting strategies exist that might target sub-populations of astrocytes, although potential candidates may be emerging. The genetic knock-in to the Gli1 locus discussed above targets reporter gene expression in the cerebral cortex selectively to scattered middle layer astrocytes that selectively respond to neuronal SHH signaling 31 . Other markers that target sub-populations of astrocytes may emerge from studies identifying signaling molecules that specify topographically restricted astrocyte lineages 33 .
Diversity and dynamics of astrocyte morphology Gross astrocyte morphological differences between different brain areas and how astrocyte morphology changes in hypothalamus during lactation, parturition and dehydration 34 have been reviewed previously [35] [36] [37] . We will focus on dynamics of the finest processes of astrocytes that form close appositions to synapses. These fine processes have been described using several terms, such as astrocyte lamellae, astrocyte sheets, veil-like lamellae, peripheral astrocyte processes, perisynaptic astrocyte processes and astrocyte fingers. We refer to them collectively as astrocyte leaflets (Box 2). All of our discussion is based on studies of rodents. It should be noted that there is considerable species variability and it is well established that humans and non-human primates possess astrocytes that are far more complex than those of rodents in terms of size and complexity of processes 5 .
Morphological complexity. A rodent 'typical' protoplasmic astrocyte consists of a soma, 4-10 major branches, and thousands of branchlets and leaflets that lie close to synapses (Fig. 1a and Box 2). Astrocytes have highly complex spongiform shapes with diameters of ~40-60 µm and volumes of ~6.6 × 10 4 µm 3 (refs. 38,39) . About 90-95% of an astrocyte's area is formed by branches, branchlets and leaflets 40 ( Fig. 1a) , and only ~15% can be observed by GFAP staining 38, 40 . Neighboring astrocytes display very well-delineated territories and interdigitate at the edges 38 by as little as ~5% (Fig. 1b) . Comparisons between light and electron microscopy show that leaflets cannot be imaged with conventional light microscopy and that they display dimensions on the 10-100-nm scale at sites of interactions with synapses 41 . Thus, astrocytes are markedly complex cells (Fig. 1a and Box 2). The functional implications of this complexity and their regional differences are beginning to be explored.
Astrocyte morphology, the number of synapses contained in individual astrocyte territories and the proximity of astrocyte leaflets to synapses varies between brain areas 35, 36 and changes dramatically during disease and injury 37 . For example, in hippocampal stratum • Is the response of a defined population of astrocytes to injury and disease homogenous or heterogeneous?
• Can genetic markers and tools be exploited to study genetically specified populations of astrocytes and their functions in circuits?
• Can astrocyte diversity be exploited to produce desirable effects in neural circuits in the context of CNS disorders?
• How does slow and global signaling in astrocytes contribute to the functioning of specific neural circuits?
• How do changes during hypertrophic reactive astrogliosis triggered by different insults affect neural circuits? npg r e v i e w radiatum, individual astrocytes form territories that contain ~140,000 synapses 38, 39 and, of these, ~57% have juxtaposed astrocyte leaflets 42 . In neocortex, however, this number may be as low as ~30%, and, in cerebellum, almost all synapses onto Purkinje neurons are contacted by leaflets of Bergmann glia 36 , a specialized radial astrocyte. Astrocyte leaflets are generally irregular, thin and sheet-like in shape, with a clear cytoplasm that contains glycogen granules and ribosomes 36 . Astrocyte leaflets are devoid of GFAP, which is found only in major branches 37, 40 , and leaflets lack organelles such as mitochondria, microtubules and endoplasmic reticulum.
Real-time dynamics of astrocyte leaflets. Studies of hippocampal stratum radiatum have found that most dendritic spines are contacted by astrocyte leaflets, which impinge on about one third of the available perimeter of individual synapses 42 . Synapses with astrocyte leaflets at their perimeters tend to be larger than those without 43 , suggesting that interactions of astrocyte leaflets and synapses may be correlated with synaptic strength 44 . Recent studies using time-lapse imaging methods in situ and in vivo suggest that astrocyte leaflet motility increases in response to synaptic activity and is associated with increased synapse coverage and spine stability 45 . Hippocampal astrocyte leaflet motility was triggered by synaptic glutamate release and mediated by astrocyte metabotropic glutamate receptors and intracellular Ca 2+ elevations 45 . Moreover, stimuli that caused long-term synaptic potentiation (LTP) of synapses also caused astrocyte leaflets to increase their motility (over ~10 min), which then stabilized after ~30 min around enlarged synapses 45 , recalling electron microscopy data 46 . Key findings were extended to in vivo imaging of astrocytes in the barrel cortex during whisker stimulation, demonstrating that observations made in situ were relevant in the context of an intact brain 45 . Consistent with this, previous studies found that whisker stimulation increases astrocyte coverage of synapses in the barrel cortex 47 . Broadly similar conclusions were reached using different methods 48 , but these authors suggest that astrocyte leaflet structural changes may control astrocyte ability to regulate synapse function 48 . Thus, astrocyte morphology and leaflet proximity to synapses is dynamic and regulated by neuron-to-astrocyte signaling.
An unexpected role for Cx30 in astrocyte morphology and leafletsynapse proximity. Molecular mechanisms that determine astrocyte leaflet proximity to synapses are unclear, but may involve the actinbinding proteins profilin 1 and ezrin, which have been implicated in Ca 2+ -dependent astrocyte process outgrowth 49, 50 . Moreover, glutamate causes astrocyte filopodial outgrowth 51 . Recent experiments have revealed a new mechanism involving connexin 30 (Cx30), a gap junction protein that is found postnatally in astrocytes 52 . By using Cx30-deletion mice, Pannasch et al. 52 found a Cx30 function independent of its ion channel pore: loss of Cx30 resulted in significantly greater astrocyte process elongation and ramification in the neuropil. The altered astrocyte morphology explains decreased excitatory synaptic function in Cx30 mice because the closer proximity of astrocyte leaflets to synapses increased glutamate transporter numbers near synapses. The ensuing downstream effects include decreased AMPA
Box 2 Suggested general terminology for astrocyte subcompartments
Emerging evidence suggests that all astrocyte processes are not the same either functionally or morphologically. We suggest that the term astrocyte process should be replaced by several distinct terms:
• Branches are the major processes emanating from the astrocyte soma. These probably do not number more than eight per astrocyte and display diameters on the micrometer scale and have also been called stem processes.
• Branchlets are the finer secondary, tertiary and higher order structures that emanate from branches. The precise number of these is unknown, but they display diameters on the sub-micrometer scale. Diffraction limited light microscopy is not ideal for studying the finest branchlets, although they can clearly be seen as being distinct from branches.
• Leaflets are the very terminal extensions of astrocyte branchlets that contact synapses. The precise numbers of these per astrocyte is unknown, but on the basis of electron microscopy studies, they display dimensions on the scale of hundreds of nanometers. Leaflets would be the same structures as those variously termed astrocyte lamellae, astrocyte sheets, veil-like lamellae, peripheral astrocyte processes, perisynaptic astrocyte processes and astrocyte fingers. Leaflets cannot be imaged with diffraction-limited light microscopy.
• End feet are specialized distal extensions of astrocytes that contact the vasculature. It is likely that each astrocyte bears only one or two branches with end feet. End feet appear to represent a uniquely specialized and polarized compartment of astrocytes. npg r e v i e w receptor-mediated synaptic transmission, reduced hippocampal LTP and reduced contextual fear memory 52 . Thus, differences in astrocyte leaflet proximity to synapses have strong effects on synapses, circuits and behavior 52 . In addition, astrocyte leaflet motility may be needed for maturation of dendritic spines during development 53 . Astrocyte morphology is controlled by FGF receptor signaling 54 in Drosophila and by mGluR5-dependent glutamate signaling in the case of rodent cortical, but not hypothalamic, astrocytes during development 55 .
Bergmann glia AMPA receptors and Purkinje cell synapses. Bergmann glia express GluA1 and GluA4 AMPA receptor subunits and functional AMPA receptors. Ca 2+ -permeable GluA1-containing AMPA receptors on Bergmann glia are needed for correct association of Bergmann glial processes with Purkinje cell synapses 56 . Genetic disruption of AMPA receptor Ca 2+ permeability in Bergmann glia resulted in prolonged kinetics of glutamate synaptic transmission and multiple innervations of Purkinje cells by climbing fibers 56 . In adult mice, genetic deletion of Bergmann glia AMPA receptor subunits resulted in retraction of glial processes from the vicinity of synapses, altered synaptic transmission and changes in fine motor coordination of the mice 57 . Together, these studies provide compelling evidence for the physiological relevance of a specific type of AMPA receptor-mediated Ca 2+ signaling mechanism in vitro and in vivo, underscoring astrocyte morphological dynamics and the realization that Ca 2+ signals are diverse and not all mediated by intracellular release 58 . As far as we know, there is no evidence that cortical astrocytes express functional AMPA receptors.
Diversity and dynamics of Ca 2+ signals in single astrocytes
Astrocyte Ca 2+ signaling has attracted much interest [59] [60] [61] [62] because it represents a form of signaling that astrocytes may use for intercellular communication [63] [64] [65] . Until recently, there has been little emphasis on work that provides evidence for Ca 2+ signal diversity. Exploration of this issue has benefited from development of genetically encoded calcium indicators (GECIs) [66] [67] [68] , and there is now strong evidence that astrocytes display diverse Ca 2+ signals in sub-compartments [69] [70] [71] [72] [73] ( Fig. 2 and Box 2) .
Diverse types of Ca 2+ signals observed in astrocytes. The first type of numerically dominant astrocyte Ca 2+ signal appears as spontaneous highly localized microdomains in branches and branchlets [69] [70] [71] [72] 74, 75 . These signals are not triggered by action potential firing in neurons and only a component are mediated by Ca 2+ release from IP3R2-dependent intracellular Ca 2+ stores 72 .
The second type of Ca 2+ signal is also a localized microdomain and has been observed in astrocytes from CA1 and dentate gyrus (DG) fields in hippocampus 76, 77 , but these signals are neuronally mediated. Similarly, in DG astrocytes, a fraction of spontaneous Ca 2+ signals are caused by spontaneous action potential firing in brain slice preparations 77 . This type of action potential-dependent spontaneous Ca 2+ signal was not observed in CA3 astrocytes 72 .
The third type of Ca 2+ signal is a local wave that usually encompasses large branches and occasionally the somata; these occur spontaneously and can spread a few tens of micrometers 72 .
The fourth type of Ca 2+ signal is a global wave that encompasses entire astrocytes, including their somata. This type of signal is largely reduced in IP3R2 deletion mice, and, in CA3, can only be triggered by intense bursts of action potentials in mossy fiber axons that innervate the stratum lucidum 72 . In some instances, astrocyte somata may display spontaneous Ca 2+ elevations that are not part of a global wave and are not correlated with Ca 2+ signals in branches or branchlets.
A fifth class of Ca 2+ signal occurs in endfeet and is mediated by Ca 2+ release from IP3R2-dependent stores 78 and Ca 2+ entry via TRPV4 channels 79 .
A sixth type of Ca 2+ signal occurs in vivo during locomotion and startle responses. Here, the Ca 2+ signals are extremely broad and cover essentially all astrocytes in the imaging field of view and are driven by volumetric release of neuromodulators 73, 75, 80 .
Finally, long-lasting (~70 s) and highly localized Ca 2+ twinkles have been recorded in cortical astrocyte branchlets in vivo 81 . Diverse Ca 2+ signals have been observed in Bergmann glia 82 of the cerebellum. In summary, a rich diversity of Ca 2+ signals exists in single astrocytes. These are mediated by distinct mechanisms and occur in distinct CNS locations.
Diverse functions of Ca 2+ signals in astrocytes. What do diverse types of Ca 2+ signals do in astrocytes? A complete answer to this question will require methods to mimic and block distinct types of Ca 2+ signals precisely so that their consequences can be explored in specific circuits under specific settings 60 . In addition, a generic tool to block the vast majority of Ca 2+ signals in astrocytes is needed. There is unlikely to be a single physiological role for astrocyte Ca 2+ signals that will apply to the whole CNS. It seems likely that distinct Ca 2+ signals will regulate the release of signaling molecules via a variety of possible pathways 83 (but see ref. 84): controlling blood vessel diameter 85 , controlling the release of synaptogenic and trophic factors 1, [86] [87] [88] , regulating gene expression, modulating K + uptake 89 , regulating neurotransmitter uptake 71 , contributing to neuromodulation 75, 80, 90 , controlling movement of astrocyte leaflets 45, 48, 49 , contributing to axonal action potential broadening 91 , controlling neuronal synchronization 92 , contributing to UP states 93 , and perhaps controlling the release of injury-related molecules and inflammatory mediators 94 . All of these phenomena are regulated by astrocyte Ca 2+ signals and need to be explored with respect to the distinct types of recently discovered Ca 2+ signals. It is implausible that all of these effects could be mediated by a single type of Ca 2+ signal in a single type of astrocyte. From this perspective, the multitude of functional responses mediated by astrocytes provides the best indication yet for diversity in microcircuits. The key conceptual advance is that astrocytes display diverse Ca 2+ signals in branches and branchlets that are spatially and temporally unrelated to those in the somata (Fig. 1b) and are distinct in circuits and microcircuits, emphasizing diversity of signaling in single cells npg r e v i e w and compartments. These insights 73 challenge the view that astrocytes display a single type of intracellular Ca 2+ signal 58, 95 .
In vivo and in situ tools to study Ca 2+ signals in entire astrocytes. There has been tremendous progress in the generation and testing of strategies to express genetically encoded Ca 2+ indicators in astrocytes. These are now the tools of choice for studying astrocyte Ca 2+ signals ( Table 1) .
Diverse astrocyte responses in circuits and microcircuits We adopted Shepherd and Grillner's thoughtful definition 96 of a brain microcircuit as the way nerve cells (and associated cells such as glia) are organized to carry out specific operations in a region of the nervous system. We do not consider direct fast-acting gliotransmission, as the arguments for 83 and against 84 have been reviewed.
Hippocampus. High-resolution imaging of Ca 2+ signals in astrocyte branches using two-photon microscopy provides evidence for diversity of astrocyte functional responses in different hippocampal fields. Astrocytes in CA1 stratum radiatum respond with an increase in Ca 2+ in major astrocyte branches during minimal stimulation of Schaffer collateral fibers 76 . These responses are mediated by synaptic glutamate release acting on mGluR5 metabotropic glutamate receptors on astrocytes 76 . The resultant increase in astrocyte Ca 2+ is proposed to evoke the release of gliotransmitters (for example, ATP), which most likely, via the production of adenosine, act on presynaptic A2A receptors to regulate neurotransmitter release probability 76 . Astrocytes located in DG display two types of Ca 2+ signals that are termed focal and expanded; the latter are caused by action potential firing and the focal signals are mediated by spontaneous synaptic neurotransmitter release 77 . Focal and expanded Ca 2+ signals are mediated by synaptic ATP because both types of Ca 2+ signal are reduced by a P2Y1 receptor antagonist and both are mediated by Ca 2+ release from IP3R2-dependent intracellular Ca 2+ stores 77 . It is suggested that astrocyte Ca 2+ signals in DG function to regulate the probability of excitatory neurotransmitter release onto granule cells, perhaps via astrocytic release of a neuromodulator that acts on presynaptic nerve terminals 77 . Thus, astrocytes are proposed to act as rapid local detectors of neuronal activity and to respond to activity changes by locally regulating neurotransmitter release from the same synapses.
In contrast, astrocytes located in CA3 stratum lucidum region only respond during intense bursts of action potentials evoked in mossy fiber axons, and display Ca 2+ signals that are mediated largely by mGluR2/3 receptors and encompass large parts of the astrocytes 72 . Hence, CA3 astrocytes do not respond to sparse neuronal input and seem incapable of regulating synapses locally because their Ca 2+ signals cover entire cells. Instead, they may control neuronal network synchronization 92 . Serial block-face electron microscopy provides one explanation for differences between CA1 and CA3 region astrocytes. The fine leaflets of astrocytes are much closer to excitatory synapses in the CA1 region than the leaflets of CA3 astrocytes are to mossy fiber synapses 72 , illustrating that astrocyte sub-cellular anatomy and function varies in hippocampal fields.
There is additional evidence that distinct types of Ca 2+ signals may serve distinct functions. LTP in CA1 pyramidal neurons is largely reduced when astrocytes are dialyzed with Ca 2+ chelators 97 , but is unaffected when intracellular store mediated astrocyte Ca 2+ signals are reduced or increased 95 . These findings may be explained by the variable dependence of LTP on the source of astrocyte Ca 2+ . Hence, basal, rather than elevated, astrocyte Ca 2+ signals may be important for LTP by regulating the constitutive release of d-serine 98 . The available data suggest that astrocyte functional roles are distinct in microcircuits that comprise the larger hippocampal circuit and are separable for distinct sources of Ca 2+ in single astrocytes. These insights underscore the importance of studying specific and defined types of Ca 2+ signal for specific neural responses under specified conditions.
Cerebellum. Bergmann glia display highly localized microdomain Ca 2+ increases that can be evoked by electrical stimulation of afferent fibers 99 . Studies using in vivo imaging in awake head fixed mice free to rest or run on a freely moving ball 100 revealed three types of Ca 2+ signals within Bergmann glia of the cerebellum 90 . Two types of ongoing and spontaneous Ca 2+ signals in the cerebellum of mice at rest were termed sparkles and bursts, whereas a third form called flares occurred in hundreds of Bergmann glia in a concerted manner during locomotor activity. Sparkles occurred mainly in processes and were reduced by tetrodotoxin (TTX) and glutamate receptor antagonists 90 . Bursts occurred spontaneously in mice at rest and appeared as radially expanding waves that encompassed ~55 Bergmann glia 90 and a volume of ~86,000 µm 3 . These signals were not sensitive to TTX, but were abolished by an ATP receptor antagonist, implying they were a result of endogenous ATP 90 being released from astrocytes themselves 101 . Flares occurred during voluntary running and encompassed hundreds of Bergmann glia and were abolished by TTX and a glutamate receptor antagonist 90 . Thus, a single type of astrocyte can display a variety of responses and mechanisms in vivo depending on the behavior of the mouse.
Bergmann glia and cortical astrocytes both respond during periods of enforced locomotion in ways that are indicative of arousal or heightened vigilance states, rather than locomotion per se 75, 80 . Under these circumstances, the responses were coincident in these anatomically distinct brain areas, were global because all imaged cells displayed Ca 2+ signals (Fig. 3) , and, in both brain areas, the responses were mediated by noradrenaline acting on α1 adrenoceptors located on astrocytes and Bergmann glia 75 . Noradrenaline was likely released from varicose terminals of locus coeruleus neuron projections that extend throughout much of the brain, as cortical astrocytes displayed Ca 2+ elevations when locus coeruleus neurons were electrically stimulated 102 . As such, astrocyte responses in cortex and cerebellum may be indicative of a global brain state associated with arousal or startle. npg r e v i e w
Thalamus. The thalamic reticular nucleus (nRT) is a source for endogenous benzodiazepine-mimicking peptides called endozepines 103 . Recent work revealed that endozepine peptides are found in astrocytes of nRT, and the use of a gliotoxin showed that astrocytes are needed for their positive allosteric effects on synaptic inhibition 104 . The effect of gliotoxin was to reduce inhibition in nRT, as the toxin removed a source of endogenous endozepines in nRT 104 . However, the effect of gliotoxin in the ventrobasal nucleus (VB) was to increase inhibition via a mechanism that involved GABA transporters. Thus, astrocytes located in adjacent nRT and VB microcircuits have distinct effects on inhibitory synapses mediated by endozepines and GABA transporters, respectively.
Medulla. The retrotrapezoid nucleus (RTN) of the medulla is an important site of chemoreception that allows hypercapnia (an increase in blood CO 2 ; pCO 2 ) to increase breathing. A subset of neurons in RTN are highly sensitive to CO 2 /H + and send excitatory glutamatergic projections to respiratory centers to regulate breathing. CO 2 /H + -evoked ATP release from astrocytes in the vicinity of RTN influences respiratory drive 105 by regulating RTN neuron firing. Thus, astrocytes located near RTN are the cellular sources of ATP mediating the ATP component of the central chemosensory response to hypercapnia. Notably, astrocytes in this area are particularly pH sensitive, responding with Ca 2+ elevations and further release of ATP 105 . This study suggests that a vital step in central chemoreception involves ATP release from astrocytes located on the ventral medulla surface and that this signal is propagated by astrocyte ATP release, ultimately arriving at RTN neurons to depolarize them and thereby regulate breathing 105 . As such, a potentially unique class of astrocytes in the respiratory chemoreceptor areas displays exquisite pH sensitivity and mediates direct effects on the ability to change breathing following changes in pCO 2 /H + .
Spinal cord. There is strong evidence for positionally distinct astrocyte subtypes in the spinal cord 106, 107 . Evidence that astrocytes in distinct domains are functionally diverse has been provided by examining differential gene expression between dorsal and ventral spinal cord astrocytes 32 . Sema3a was the most highly expressed ventral gene and this pattern was confirmed by protein expression 32 . Loss of Sema3a in ventral astrocytes had consequences for α-motor neurons: defective axon initial segment orientation, abnormal synapse formation and function, and α-motor neuron loss 32 . Cell culture studies have suggested that the positional identity of astrocytes is intrinsic, as the relevant properties are retained in co-cultures independent of local environment. These studies raise the possibility that distinct populations of astrocytes serve distinct functions in microcircuits and provide approaches to tackle this issue in other circuits. Irrespectively, studies of dorsal-ventral differences in spinal cord astrocytes provide evidence for regional neural circuit diversity of molecular machinery and function 32, 106 .
Two broadly defined types of Ca 2+ signal and responses in circuits: local and global. Recent in vivo studies represent a milestone because they provide a basis to explore and understand the physiological settings under which astrocytes respond to behaviors that are engaged in the intact brain. Although this is a nascent field, several general points are worth noting. First, during locomotion, the responses of astrocytes in the cortex and Bergmann glia were correlated, implying that the underlying causes may be widespread 75 . Second, when astrocytes responded during locomotion, their responses were largely global and not localized to single cells or areas of single cells 73, 75, 102 . Third, astrocyte responses were mediated by a slow neuromodulator and not by a fast neurotransmitter 75, 80 . Together, these data suggest that astrocytes respond to slow neuromodulators that are released as volumetric transmitters 80 , and when astrocytes respond they do so over large parts of their territories. Moreover, in vivo responses and those in the CA3 region indicate that astrocytes may only modulate neuronal function on slow timescales and over large distances 72, 73, 75, 80, 90, 102 . These slow and global responses are distinct from local responses shown for CA1 and DG astrocytes 76, 77 . Notably, responses of layer 2/3 visual cortex astrocytes to light were enhanced markedly by enforced locomotion 75 , which implies that local and global signals act synergistically. Synergism for astrocyte Ca 2+ signals evoked by noradrenaline and VIP receptors has been demonstrated in vitro 108 , and these experiments are relevant in the context of in vivo work in which both noradrenaline and VIP are likely to be released during startle. There is also evidence that astrocytes display Ca 2+ elevations during endogenous release of acetylcholine, which acts on astrocyte muscarinic receptors 109, 110 . It seems likely that astrocytes may respond to local signals and to volumetric signals depending on the particular conditions and brain region.
Diversity of astrocyte roles in CNS disorders
Astrocytes respond to all forms of CNS damage and disease by undergoing cellular, molecular and functional changes commonly referred to as reactive astrogliosis. In addition, recent observations indicate that astrocyte dysfunction can have causal roles in certain CNS disorders and that the neurological consequences of astrocyte dysfunctions can precede the onset of detectable reactive astrogliosis. Thus, astrocyte roles in CNS disorders exhibit diversity and can be npg r e v i e w primary as well as reactive or secondary. A better understanding of this diversity could affect the understanding and treatment of CNS injury and disease. Reactive astrocyte changes associated with neuropathology and disease have been reviewed previously 17, 94, 111, 112 . We focus on examples illustrating diversity of astrocyte functional roles in CNS disorders. Astrocyte effects in Huntington's disease (HD) models. HD is caused by an expanded chain of polyglutamines in the huntingtin protein (HTT), leading to intracellular accumulation and aggregation of mutant HTT (mHTT). HD patients and mouse models of HD exhibit nuclear inclusions of mHTT in striatal astrocytes 113 . Recent findings indicate that the onset and progression of neurological disease in HD mouse models is associated with specific astrocyte dysfunction in striatum, but not hippocampus, suggesting a neural circuit-specific nature of astrocyte roles in HD. Tong et al. 114 found, using two HD mouse models, that, in comparison with pre-symptomatic stages, the onset of neurological symptoms was associated with a significant increase in astrocytes with mHTT nuclear inclusions and significant reductions in astrocyte functional proteins, including GLT-1 (EAAT2) and Kir4.1. At symptom onset, and in spite of clear evidence of astrocyte dysfunction, there were no major phenotypic changes associated with astrocyte reactivity, such as proliferation, hypertrophy and increased GFAP expression. These findings indicate that mHTT is associated with disruption of the expression of important astrocyte functional proteins that initially alter astrocyte function without noticeable astrogliosis. Loss of the glutamate transporter GLT-1 (EAAT2) has been extensively studied in the context of HD 115 . Kir4.1 potassium channels regulate extracellular K + levels and are expressed in the CNS primarily by astrocytes 116 . Loss of Kir4.1 currents in striatal astrocytes in HD mouse models 114 led to higher ambient K + , which increased medium spiny neuron (MSN) excitability, a hallmark of HD mouse models 117 , and these deficits could be rescued by virusmediated delivery of Kir4.1-GFP channels selectively to astrocytes, thereby providing evidence that subtle increases in extracellular K + resulting from astrocyte Kir4.1 loss can phenocopy MSN changes in HD mouse models. Together, these findings support the hypothesis that key aspects of altered MSN excitability in HD are caused by the specific primary dysfunction of a key astrocyte homeostatic function, maintenance of extracellular K + , and are not merely a generic or nonspecific secondary consequence of astrocyte reactivity. This notion is relevant in the context of human HD, which displays a progressive increase in astrocyte reactivity over time. Thus, astrocyte contributions to underlying HD pathological mechanisms are diverse and change with the progression of disease, such that early stages of the disease are associated with functional deficits in Kir4.1 and GLT-1 (EAAT2) and later stages are also associated with increasing astrocyte reactivity. Therapeutic strategies targeting astrocytes need to embrace the concept that astrocytes display a range of specific dysfunctions as well as astrogliosis.
Astrocyte changes in Alzheimer's disease models. A mouse model of familial Alzheimer's disease displayed elevated basal cortical astrocyte Ca 2+ levels and increased Ca 2+ transients termed hyperactive Ca 2+ signaling 118 . Neither normal nor hyperactive Ca 2+ signaling was the result of action potential firing in neurons 119 . Hyperactivity arose because reactive astrocytes near β-amyloid plaques displayed enhanced P2Y1 receptor-mediated Ca 2+ signaling 119 . The hyperactive phenotype could be rescued by blocking ATP release from connexin channels and by blocking P2Y1 receptors 119 . Together, these data indicate that astrocyte hyperactivity in Alzheimer's disease may be caused by a combination of ATP release and/or increased P2Y1 receptor expression by a population of astrocytes near plaques, implying that blocking P2Y1 receptors represents a therapeutic strategy for Alzheimer's disease. These observations also point toward diversity of astrocyte responses to different CNS insults. P2Y1 receptor mRNA expression and Ca 2+ signaling was markedly reduced in in vitro models of astrocyte reactivity triggered by inflammatory mediators 27 , suggesting that the increase observed around β-amyloid plaques may represent a previously unknown cellular phenotype specific to Alzheimer's disease.
Diversity of astrocyte secondary responses to injury and disease. Considerable information has accrued regarding molecular and structural aspects of reactive astrogliosis 17, 94, 111, 120, 121 . Recent progress demonstrates that, in contrast with long-held beliefs, reactive astrogliosis is not a uniform set of stereotypic astrocyte changes regulated by a simple single genetic on-off switch. Instead, molecular dissection in vivo has revealed that diverse signaling events tailor astrocyte responses to specific CNS insults 94, 111 . For example, transcriptional changes induced by either ischemia or inflammation differ substantially 27, 28 , and trauma-induced changes exhibit clear gradients that vary with distance from lesions and with injury intensity 17, 122 . Thus, reactive astrogliosis is both complex and heterogeneous and can be defined as a finely graded continuum of multiple potential changes that range from reversible alterations in gene expression and cell hypertrophy in preserved individual astrocyte domains to scar formation that involves substantial cell proliferation and permanent rearrangement of tissue structure 17, 94, 111 . Thus, reactive astrocytes exhibit substantial diversity at multiple levels, including with respect to gene expression, cell structure, cell signaling and cell function. This diversity exists not only across different CNS regions, such as cerebral cortex, hippocampus and spinal cord, but also topographically with respect to distance from lesions and locally among neighboring cells 27, 122, 123 .
Two functionally distinct categories of reactive astrocytes. Much of the evidence that delineates heterogeneity among reactive astrocytes pertains to differences in molecular expression and cell structure. Although less is known about functional diversity, current information points toward a working model that recognizes at least two fundamentally distinct broad functional categories of reactive astrocytes, which we refer to as scar-forming reactive astrocytes and hypertrophic reactive astrocytes. (Fig. 4 and Table 2 ).
In response to focal tissue damage or inflammation, scar-forming reactive astrocytes in all CNS regions form scar borders that segregate damaged and inflamed tissue from adjacent viable and functioning neural tissue 17, 112, 124 . In forebrain, including cortex, hippocampus and thalamus 125, 126 , and spinal cord 122 , astrocyte scar borders are comprised almost entirely of newly proliferated astrocytes that do not observe discrete individual cellular domains and have elongated processes that intertwine extensively 122 (Fig. 4c) . There is currently evidence for at least two different potential sources of newly proliferated scar-forming astrocytes. The first is from proliferation of local mature perivascular astrocytes, as demonstrated by in vivo imaging of cerebral cortex 127 . A second source is from migrated progeny of periependymal neural progenitors 128, 129 . The potentially diverse manners in which different sources of newly proliferated astrocytes contribute to scar formation or other injury responses in different CNS regions are not yet defined. Nevertheless, an emerging overall function of scar-forming astrocytes in response to severe tissue damage after trauma, stroke or infection is the formation of functional barriers that sharply demarcate tissue compartments in which robust inflammatory responses can occur that are essential for clearing debris and neutralize microbial pathogens while preserving immediately adjacent viable and functioning neural tissue 94, 112, 124 . Thus, the primary cellular interactions of scar-forming astrocytes are with multiple types npg r e v i e w of non-neural cells, including leukocytes, other inflammatory cells and fibrotic cells (Fig. 4c) . Astrocyte scar formation is associated with permanent rearrangement of tissue architecture.
In response to mild or diffuse CNS insults, or in tissue adjacent to scar borders around focal lesions, astrocytes in all CNS regions undergo molecular, structural and functional changes that stop short of proliferation and scar formation, which we refer to collectively as hypertrophic reactive astrogliosis 17, 94, 111 . In these responses, hypertrophic reactive astrocytes (i) are comprised of non-proliferating resident astrocytes 112, 122 , (ii) remain in their original locations and do not migrate 127, 130 , (iii) exhibit a wide variety of potential changes in molecular expression 94, 111 , (iv) exhibit varying degrees of cellular hypertrophy 94, 111 , but (v) retain their processes more or less in their individual cellular domains in gray matter 131 , and (vi) continue to interact with the same local cells as before the insult. Changes associated with hypertrophic astrogliosis have the potential to vary with the nature of triggering insult, CNS region involved, distance of the astrocytes from an insult and presence of co-morbid factors such as peripheral infections, and most changes appear to be reversible in situations in which insults resolve, for example, after single event traumatic or ischemic injuries. Functionally, the primary cellular interactions of hypertrophic reactive astrocytes remain with the same neural cells that they interacted with in healthy tissue before the insult, either neurons or oligodendrocytes (Fig. 4a,b) . Although reactive astrocytes undergo many molecular changes, including in transporters critical for the extracellular homeostasis of ions, transmitters and water 111, 132, 133 , little is known about the functional consequences of those changes (Fig. 4b) . One early study on this topic reports that mild hypertrophic astrogliosis secondary to viral infection is associated with decreased neuronal inhibition in hippocampus 134 . Even though hypertrophic astrogliosis is ubiquitous in all perimeter regions of functioning neural tissue around all forms of focal injury caused by stroke or trauma, as well as in all areas of chronic neurodegeneration in all CNS regions 112 , little is known about the effects of hypertrophic reactive astrogliosis on microcircuit function and whether, or how, these effects might differ in different regions or whether they are detrimental or beneficial in differing circumstances.
Delineating these two broad functional categories of scar-forming and hypertrophic reactive astrocytes does not preclude additional levels of diversity in or in addition to those categories. Although all reactive astrocytes may not precisely fit, recognition of these categories will aid in experimental design, comparison of results, discussion and understanding. For example, reactive astrogliosis and scar formation are often regarded as synonymous, but this is not the case. The molecular mechanisms and functions of scar-forming astrocytes that are newly proliferated and motile, and that function primarily to regulate inflammatory cells 112, 130 , will be fundamentally different from the molecular mechanisms and functions of hypertrophic reactive astrocytes that remain in situ and retain, but modify, their interaction with local neurons and synapses (Fig. 4) . Future investigations to dissect mechanisms and functions of reactive astrocytes will need to take into consideration and clearly define the type of reactive astrocyte that is being investigated, the nature of the triggering insult, the distance from that insult and the CNS region being studied.
Distinguishing reactive astrogliosis from astrocyte dysfunction. Transgenic loss-of-function studies applied to in vivo models of CNS insults have shown that, under normal circumstances, astrogliosis and scar formation serve essential functions that limit tissue damage, restrict inflammation and preserve function after CNS traumatic injury, stroke, infection, autoimmune attack and degenerative disease 17, 94, 111, 112, 120, 121, 130 . Emerging data also indicate that primary astrocyte dysfunctions can contribute to neuronal dysfunction and neurological symptoms before the onset of detectable astrogliosis 114 . Thus, astrocyte dysfunction and astrogliosis are not synonymous and can occur independently of each other. The emergence of a concept of 'normal astrogliosis' that is critical for preservation of tissue and function after CNS insults, has led to the recognition that astrogliosis can also be prone to dysfunction as a result of genetic defects, genetic polymorphisms, autoimmune attack or chronic exposure inflammatory stimuli caused by secondary infections 94 . Recognizing and understanding the differences between beneficial and dysfunctioning astrogliosis is likely to be fundamental to dissecting the cellular mechanisms underlying many CNS disorders. Emerging questions. A first class of question concerns molecular mechanisms. What is the molecular makeup and signaling machinery of astrocytes in distinct circuits? By systematically comparing between different brain circuits it should be possible to assemble a set of molecular metrics with which to classify astrocytes as distinct or the same in different regions. Do astrocytes utilize signals other than Ca 2+ for cellular communication? New families of highly specific genetically encoded indicators for neurotransmitters and neuromodulators are needed. We also need to measure the nature and amounts of substances released from astrocytes in specific brain areas and then explore the functions of key signaling species on a case-by-case basis in the context of specific circuits and behaviors.
A second class of question concerns how astrocytes contribute to the formation and function of synapses and circuits. Do individual astrocytes signal locally to single or small sets of synapses to allow formation or removal, or do single astrocytes signal globally to entire dendritic arbors in their territory or perhaps even to entire populations of neurons that reside in extended astrocyte volumes connected by gap junctions? Are synapse formation and removal triggered by activity-dependent and bidirectional signaling between astrocytes and neurons? If so, what chemical signals are involved, are they unique and can they be exploited pharmacologically? What do the various types of astrocyte Ca 2+ signals encode in circuits? Is the main function of astrocytes to listen locally to synapses and then to regulate them locally, or is it to listen to widespread volumetric neuromodulator release and respond globally over large volumes of brain? Studies demonstrating motility of astrocyte leaflets are important because altering astrocyte proximity to synapses has the potential to alter synaptic and circuit function by altering ion and neurotransmitter homeostasis.
A third class of question concerns astrocyte functional diversity in CNS disorders. Astrocytes display a plethora of changes in CNS disorders, but which of these are correlative, beneficial or harmful will need to be determined on a case-by-case basis. Studies will need to explore astrocyte contributions to specific conditions in specific brain areas and at specific stages of pathology and avoid the temptation to generalize across the spectrum of disorders ranging from traumatic injury to neurodegenerative diseases. In this regard, it is noteworthy that astrocytes perform specialized functions in higher primates 135 , and it is possible that astrocyte diversity is greater in humans than in rodents. It is likely that in vitro studies of astrocytes derived from patient-induced pluripotent stem cells will be fruitful. Much could be learned about the regional and functional diversity of astrocytes and their contributions to pathology and neural circuit mechanisms in organoid systems as models for human disorders 136 .
Finally, how should one classify diverse astrocytes? We suggest that the answer will emerge from a broad understanding of functional diversity, rather than relying solely on single criteria such as morphology, connectivity, marker expression or gene profiles. Our emphasis is to define astrocyte diversity on the basis of direct measurements of function, dynamics and molecular mechanisms in specific circuits. This captures recent progress with the classification of interneurons 137 .
Summary. We conclude by advancing the concept that astrocytes display a range of functional attributes that are astrocyte compartment, circuit, microcircuit and disease specific. As such, previous notions that astrocytes represent a homogenous population of cells throughout the CNS need to be revised. A deeper understanding of astrocyte diversity and its implications is necessary to fully understand neural circuits 3 in health and disease and to provide new opportunities to treat CNS disorders.
